NASDAQ:ATXS

Astria Therapeutics (ATXS) Earnings Date, Estimates & Call Transcripts

$11.68

-0.87 (-6.93%)

(As of 06/7/2023 ET)

Compare

Today's Range: $11.65
▼
$13.00
50-Day Range: $10.24
▼
$13.72
52-Week Range: $2.36
▼
$16.28

Volume: 231,117 shs
Average Volume: 173,152 shs
Market Capitalization: $327.39 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $19.00

Upcoming Earnings Date: Aug. 8Estimated
Actual EPS (Mar. 22): -$0.72 Beat By $0.02
Consensus EPS (Mar. 22): -$0.74
Last Year's Q1 EPS (3/10/2022): -$0.73

Earnings Per Share Revenue

ATXS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATXS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Astria Therapeutics Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2023	5	($0.57)	($0.46)	($0.51)
Q2 2023	5	($0.61)	($0.51)	($0.54)
Q3 2023	5	($0.66)	($0.53)	($0.58)
Q4 2023	5	($0.69)	($0.58)	($0.62)
FY 2023	20	($2.53)	($2.08)	($2.25)
Q1 2024	1	($0.70)	($0.70)	($0.70)
Q2 2024	1	($0.70)	($0.70)	($0.70)
Q3 2024	1	($0.70)	($0.70)	($0.70)
Q4 2024	1	($0.59)	($0.59)	($0.59)
FY 2024	4	($2.69)	($2.69)	($2.69)

ATXS Earnings Date and Information

Astria Therapeutics last issued its earnings results on March 22nd, 2023. The biotechnology company reported ($0.72) EPS for the quarter, topping the consensus estimate of ($0.74) by $0.02. Astria Therapeutics has generated ($2.85) earnings per share over the last year (($2.85) diluted earnings per share). Earnings for Astria Therapeutics are expected to decrease in the coming year, from ($2.01) to ($2.23) per share. Astria Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off prior year's report dates.

Astria Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/8/2023 (Estimated)
3/22/2023	Q4 2022	($0.74)	($0.72)	+$0.02	($0.72)
11/10/2022	Q3 2022	($0.92)	($0.87)	+$0.05	($0.87)
8/9/2022	Q2 2022	($1.04)	($0.86)	+$0.18	($0.86)
5/12/2022	Q1 2022	($0.73)	($1.18)	($0.45)	($1.18)
3/10/2022	Q4 2021	($0.61)	($0.73)	($0.12)	($0.73)
11/10/2021	9/30/2021	($0.92)	($0.61)	+$0.31	($0.61)

8/8/2021	6/30/2021	($1.20)	($1.26)	($0.06)	($0.89)
5/13/2021	Q1 2021	($1.08)	($1.44)	($0.36)	$7.12
3/10/2021	12/31/2020	($2.22)	($2.64)	($0.42)	($0.45)
11/17/2020	9/30/2020	($3.06)	($3.36)	($0.30)	($0.56)
8/10/2020	6/30/2020	($2.76)	($3.18)	($0.42)	($0.53)
5/12/2020	3/31/2020	($2.46)	($3.00)	($0.54)	($0.50)
3/10/2020	12/31/2019	($3.72)	($3.30)	+$0.42	($0.55)
11/7/2019	Q3	($3.78)	($3.36)	+$0.42	($0.56)
8/8/2019	Q2 2019	($3.36)	($3.72)	($0.36)	($0.62)
5/14/2019	Q1	($3.60)	($3.72)	($0.12)	($0.62)
3/14/2019	12/31/2018	($5.58)	($5.10)	+$0.48	($0.85)
11/13/2018	Q3 2018	($9.60)	($4.80)	+$4.80	($0.08)
8/10/2018	Q2 2018	($13.80)	($12.00)	+$1.80	($0.20)
5/10/2018	Q1 2018	($13.80)	($17.40)	($3.60)	($0.29)
3/15/2018	Q4 2017	($18.60)	($14.40)	+$4.20	($0.24)	$0.25 million	$0.25 million
11/9/2017	Q3 2017	($19.80)	($18.60)	+$1.20	($0.31)		$0.25 million
8/10/2017	Q2 2017	($24.00)	($19.26)	+$4.74	($0.32)
5/11/2017	Q1 2017	($27.00)	($24.60)	+$2.40	($0.41)
3/16/2017	Q4 2016	($29.40)	($28.20)	+$1.20	($0.47)
11/10/2016	Q316	($39.00)	($32.40)	+$6.60	($0.54)
8/11/2016	Q216	($39.00)	($36.60)	+$2.40	($0.61)
5/12/2016	Q1	($38.40)	($36.60)	+$1.80	($0.61)
3/2/2016	Q415	($41.40)	($37.80)	+$3.60	($0.63)
11/12/2015	Q315	($38.40)	($33.00)	+$5.40	($0.55)
8/13/2015	Q2 2015	($42.00)	($31.80)	+$10.20	($0.53)

Astria Therapeutics Earnings - Frequently Asked Questions

When is Astria Therapeutics's earnings date?: Astria Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off last year's report dates. Learn more on ATXS's earnings history.
Did Astria Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Astria Therapeutics (NASDAQ:ATXS) reported ($0.72) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.74) by $0.02. Learn more on analysts' earnings estimate vs. ATXS's actual earnings.

How much profit does Astria Therapeutics generate each year?: Astria Therapeutics (NASDAQ:ATXS) has a recorded net income of -$51.83 million. ATXS has generated -$2.85 earnings per share over the last four quarters.
What is Astria Therapeutics's EPS forecast for next year?: Astria Therapeutics's earnings are expected to decrease from ($2.01) per share to ($2.23) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:ATXS) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Astria Therapeutics (ATXS) Earnings Date, Estimates & Call Transcripts

ATXS Earnings Estimates and Actuals by Quarter

ATXS Estimated and Actual Revenue by Quarter

Astria Therapeutics Analyst Forecasts

ATXS Earnings Date and Information

Astria Therapeutics Earnings History by Quarter

Astria Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

Astria Therapeutics (ATXS) Earnings Date, Estimates & Call Transcripts

Earnings Summary

ATXS Earnings Estimates and Actuals by Quarter

ATXS Estimated and Actual Revenue by Quarter

Astria Therapeutics Analyst Forecasts

ATXS Earnings Date and Information

Astria Therapeutics Earnings History by Quarter

Astria Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat